The longitudinal outcome of canine (K9) myxomatous mitral valve disease (LOOK-Mitral) registry: Baseline treatment characteristics
- 18 February 2022
- journal article
- research article
- Published by Elsevier in Journal of Veterinary Cardiology
- Vol. 41, 99-120
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- ACVIM consensus guidelines for the diagnosis and treatment of myxomatous mitral valve disease in dogsJournal of Veterinary Internal Medicine, 2019
- Pulmonary hypertension in left heart diseaseArchives of Medical Science, 2019
- ACVIM consensus statement: Guidelines for the identification, evaluation, and management of systemic hypertension in dogs and catsJournal of Veterinary Internal Medicine, 2018
- Effect of Pimobendan in Dogs with Preclinical Myxomatous Mitral Valve Disease and Cardiomegaly: The EPIC Study—A Randomized Clinical TrialJournal of Veterinary Internal Medicine, 2016
- Prevalence and Prognostic Importance of Pulmonary Hypertension in Dogs with Myxomatous Mitral Valve DiseaseJournal of Veterinary Internal Medicine, 2015
- Accuracy of Doppler echocardiographic estimates of pulmonary artery pressures in a canine model of pulmonary hypertensionJournal of Veterinary Cardiology, 2015
- Accuracy of Doppler Echocardiography in the Hemodynamic Assessment of Pulmonary HypertensionAmerican Journal of Respiratory and Critical Care Medicine, 2009
- Survival Characteristics and Prognostic Variables of Dogs with Mitral Regurgitation Attributable to Myxomatous Valve DiseaseJournal of Veterinary Internal Medicine, 2008
- Results of the veterinary enalapril trial to prove reduction in onset of heart failure in dogs chronically treated with enalapril alone for compensated, naturally occurring mitral valve insufficiencyJournal of the American Veterinary Medical Association, 2007
- Comparison of primary mitral valve disease in German Shepherd dogs and in small breedsJournal of Veterinary Cardiology, 2004